Daily CSR
Daily CSR

Daily CSR

Daily news about corporate social responsibility, ethics and sustainability
Tags (2) : cell therapy

Arcera–Fosun Pharma MoU to Boost Global Life Sciences & Neuroscience Innovation

Arcera–Fosun Pharma MoU to Boost Global Life Sciences & Neuroscience Innovation
04/28/2026 | Companies
Arcera Life Sciences a global life sciences firm based in Abu Dhabi, and Shanghai Fosun Pharmaceutical Group Co Ltd, an innovation-led international pharmaceutical and healthcare company, have announced the signing of a Memorandum of Understanding (MoU). This agreement establishes a long-term...
Abu Dhabi, Alzheimer’s disease, Arcera Life Sciences, biologics, biotechnology, biotechnology incubation, cardiometabolic diseases, cell therapy, China, drug development, emerging markets, Fosun Pharma, gene therapy, global healthcare, healthcare infrastructure, innovation, international collaboration, joint ventures, licensing, life sciences, market access, memorandum of understanding, Middle East healthcare, MoU, neurodegenerative diseases, neuroscience, oncology, pharmaceutical industry, R&D, radiopharmaceuticals, rare diseases, research and development, siRNA therapies, small molecules, strategic partnership, UAE, Vision 2030

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma

Advancing Cancer Treatment: Cell Therapy Insights from Kite Pharma
04/07/2025 | Companies
We're committed to advancing innovation in virology, oncology, and immunology, with a strong emphasis on supporting groundbreaking science that transforms cancer treatment. In the newest episode of The Centrifuge Sessions, Dr. Samuel Haile, Director of Cell Biology at Kite Pharma, shares insights...
biotechnology, cancer innovation, cancer research, cancer treatment, cell biology, cell therapy, immunology, innovative medicine, Kite Pharma, oncology, patient hope, Samuel Haile, The Centrifuge Sessions, virology


Want to write a piece for Daily CSR? Please contact us by email at editor[@]dailycsr.com